{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:30:14Z","timestamp":1789165814300,"version":"build-2803163510"},"reference-count":24,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,10,26]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterised by inflammatory nodules, abscesses, sinus tract formation and scarring. There is a lack of evidence for the use of radical radiotherapy for patients with a diagnosis of HS. A 56-year-old woman with a long-standing diagnosis of HS presented with a cutaneous local recurrence of breast cancer. Radical radiotherapy was offered despite issues with previous prolonged postoperative wound healing associated with the underlying HS. A multidisciplinary evaluation was conducted with breast surgeons, dermatologists and radiation oncologists to assess the safety of delivery of radical radiotherapy. Five weeks post radiotherapy, the patient had no significant residual symptoms from her breast cancer treatment for her HS and no escalation of treatment was required for her HS. Factors contributing to safe delivery of radical radiotherapy include medical optimisation prior to and during treatment, radiation dose, radiation technique and vigilant post-treatment surveillance.<\/jats:p>","DOI":"10.1136\/bcr-2020-238848","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T15:46:51Z","timestamp":1606751211000},"page":"e238848","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Delivery of high-dose radiation for recurrence of breast cancer in a patient with hidradenitis suppurativa"],"prefix":"10.1136","volume":"13","author":[{"given":"Hamoun","family":"Rozati","sequence":"first","affiliation":[{"name":"Oncology, North Middlesex University Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity J","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Dermatology, Guy\u2019s Hospital, Saint John's Institute of Dermatology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Rashidghamat","sequence":"additional","affiliation":[{"name":"Dermatology, Guy\u2019s Hospital, Saint John's Institute of Dermatology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girija","family":"Anand","sequence":"additional","affiliation":[{"name":"Oncology, North Middlesex University Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"2025082708351282000_13.11.e238848.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02536.x"},{"key":"2025082708351282000_13.11.e238848.2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2019.11.068","article-title":"Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis","volume":"83","author":"Patel","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025082708351282000_13.11.e238848.3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-Based clinical practice research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"key":"2025082708351282000_13.11.e238848.4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian hidradenitis suppurativa foundations","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2025082708351282000_13.11.e238848.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"2025082708351282000_13.11.e238848.6","unstructured":"Medicines.org.uk . Dapsone Tablets BP 50mg - Summary of Product Characteristics (SmPC) - (emc) [Internet], 2020. Available: https:\/\/www.medicines.org.uk\/emc\/medicine\/23938#PHARMACOLOGICAL_PROPS [Accessed 16 Jun 2020]."},{"key":"2025082708351282000_13.11.e238848.7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025082708351282000_13.11.e238848.8","first-page":"286","article-title":"[Radiotherapy of hidradenitis suppurativa--still valid today?]","volume":"176","author":"Fr\u00f6hlich","year":"2000","journal-title":"Strahlenther Onkol"},{"key":"2025082708351282000_13.11.e238848.9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14075"},{"key":"2025082708351282000_13.11.e238848.10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"key":"2025082708351282000_13.11.e238848.11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","article-title":"Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional study","volume":"76","author":"Deckers","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025082708351282000_13.11.e238848.12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clon.2015.01.009","article-title":"Radiotherapy for benign disease: current evidence, benefits and risks","volume":"27","author":"Taylor","year":"2015","journal-title":"Clin Oncol"},{"key":"2025082708351282000_13.11.e238848.13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.adro.2018.02.008","article-title":"Updated strategies in the treatment of benign diseases-a patterns of care study of the German Cooperative group on benign diseases","volume":"3","author":"Kriz","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"2025082708351282000_13.11.e238848.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2006.11.005"},{"key":"2025082708351282000_13.11.e238848.15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00066-012-0170-8","article-title":"Anti-Inflammatory effects of low-dose radiotherapy","volume":"188","author":"Arenas","year":"2012","journal-title":"Strahlentherapie und Onkologie"},{"key":"2025082708351282000_13.11.e238848.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.054"},{"key":"2025082708351282000_13.11.e238848.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)00435-1"},{"key":"2025082708351282000_13.11.e238848.18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jdcr.2017.02.013","article-title":"Radiation-Induced hidradenitis suppurativa: a case report","volume":"3","author":"Haber","year":"2017","journal-title":"JAAD Case Rep"},{"key":"2025082708351282000_13.11.e238848.19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdcr.2015.11.009","article-title":"A case of radiation-induced localized exacerbation of hidradenitis suppurativa","volume":"2","author":"Maher","year":"2016","journal-title":"JAAD Case Rep"},{"key":"2025082708351282000_13.11.e238848.20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jdcr.2017.05.010","article-title":"Hidradenitis suppurativa after radiotherapy for uterine adenocarcinoma: a typical example of an isoradiotopic response","volume":"3","author":"De Vita","year":"2017","journal-title":"JAAD Case Rep"},{"key":"2025082708351282000_13.11.e238848.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.01.017"},{"key":"2025082708351282000_13.11.e238848.22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jlb.62.6.827","article-title":"Anti-Inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction","volume":"62","author":"Debol","year":"1997","journal-title":"J Leukoc Biol"},{"key":"2025082708351282000_13.11.e238848.23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs Hypofractionated whole-breast irradiation: a randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"2025082708351282000_13.11.e238848.24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoncol.2015.2590","article-title":"Differences in the acute toxic effects of breast radiotherapy by fractionation schedule","volume":"1","author":"Jagsi","year":"2015","journal-title":"JAMA Oncology"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:35:21Z","timestamp":1756308921000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,30]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bcr-2020-238848"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238848","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}